4D Molecular Therapeutics In

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$15.22

+0.54 (+3.68%)

As of Sep 20, 10:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 83%

Hold 3 17%

Sell 0 0%

Price Target

Analyst Price Target +38.7% upside

Low Target $12.84

Average Target $21.11

High Target $26.25

Current Price $15.22

Current
$15.22

Target
$21.11

$12.84 $21.11 avg $26.25

Scenario Analysis

Bear Case

$12.84

-15.6%

Low target

Base Case

$21.11

+38.7%

Avg target

Bull Case

$26.25

+72.5%

High target

Risk/Reward

4.6x

Highly favorable

Price in Context

52-Week High

$16.93

-10.1% from high

52-Week Low

$6.47

+135.3% from low

Target vs 52W High

$21.11

+24.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.8%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.3%